Hostname: page-component-586b7cd67f-gb8f7 Total loading time: 0 Render date: 2024-11-27T00:30:28.043Z Has data issue: false hasContentIssue false
  • English
  • Français

Anesthesia for patients with pantothenate-kinase-associated neurodegeneration (Hallervorden-Spatz disease) – a literature review

Published online by Cambridge University Press:  24 June 2014

Jochen Hinkelbein ,
Armin Kalenka  and
Markus Alb
Jochen Hinkelbein*
Affiliation:
University Clinic for Anesthesiology and Intensive Care Medicine, Faculty for Clinical Medicine Mannheim, Ruprecht-Karls-University Heidelberg, University Hospital Mannheim, Mannheim, Germany
Armin Kalenka
Affiliation:
University Clinic for Anesthesiology and Intensive Care Medicine, Faculty for Clinical Medicine Mannheim, Ruprecht-Karls-University Heidelberg, University Hospital Mannheim, Mannheim, Germany
Markus Alb
Affiliation:
University Clinic for Anesthesiology and Intensive Care Medicine, Faculty for Clinical Medicine Mannheim, Ruprecht-Karls-University Heidelberg, University Hospital Mannheim, Mannheim, Germany
*
Jochen Hinkelbein, University Clinic for Anesthesiology and Operative Intensive Care Medicine, Faculty for Clinical Medicine Mannheim, Ruprecht-Karls-University Heidelberg, University Hospital Mannheim, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany. Tel: +49.621.383.2415; Fax: +49.621.383.732740; E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Background:

Hallervorden-Spatz disease (HSD) is a rare, progressive neurodegenerative disorder; the new and preferred name for HSD is ‘pantothenate-kinase-associated neurodegeneration’ (PKAN). Other suggested names are ‘neurodegeneration with brain iron accumulation type 1’ or ‘infantile neuroaxonal dystrophy’. Patients with PKAN have many complications, which lead to numerous anesthetic management challenges. Reports concerning the anesthetic management of patients with PKAN are very limited.

Objective:

To determine the anesthetic management and techniques as well as relevant complications for patients with PKAN.

Methods:

In this study, we review previously published literature regarding the anesthesia-relevant clinical symptoms, the anesthetic management and techniques, and possible complications for this disorder.

Results:

Only four studies describing the anesthetic management and anesthetic techniques in patients with PKAN were found. Anesthesia-relevant symptoms influence the preanesthetic management (eg difficulties in articulation, dementia), the induction of anesthesia (eg oromandibular rigidity, seizures, dysphagia, aspiration) and the postoperative care (eg respiratory disability).

Conclusion:

Reports concerning the anesthetic management of patients with PKAN are very limited, possibly as a result of the rareness of the disorder. Like many other patients with neurodegenerative diseases, patients with PKAN have many anesthesia-relevant symptoms, leading to numerous anesthetic management challenges. In general, the anesthetic complications associated with PKAN are usually no different from those associated with other neurodegenerative diseases, and the management of these are usually concordant.

Keywords

anesthetic managementHallervorden-Spatz diseasepantothenate-kinase-associated disorderneurodegeneration
Type
Brief Report
Information
Acta Neuropsychiatrica , Volume 18 , Issue 3-4 , June 2006 , pp. 168 - 172
Copyright
Copyright © 2006 Blackwell Munksgaard

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Adams, RJ, Nichols, FT, McKie, K, Milner, P, Gammal, TE. Hallervorden Spatz syndrome: clinical and magnetic resonance imaging correlations. Ann Neurol 1988;24:692–694Google Scholar
Hallervorden, J, Spatz, H. Eigenartige Erkrankung im extrapyramidalen System mit besonderer Beteiligung des Globus pallidus und der Substantia nigra: Ein Beitrag zu den Beziehungen zwischen diesen beiden Zentren. Z Ges Neurol Psychiat 1922;79:254–302CrossRefGoogle Scholar
Hayflick, SJ, Westaway, SK, Levinson, Bet al. Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. N Engl J Med 2003;348:33–40CrossRefGoogle ScholarPubMed
Kopor, S, Hortnagel, K, Gogia, S, Paul, R, Malhotra, V, Prakash, A. Pantothenate kinase associated neurodegeneration (Hallervorden-Spatz syndrome). Indian J Pediatr 2005;72:261–263CrossRefGoogle Scholar
Zhou, B, Westaway, SK, Levinson, B, Johnson, MA, Gischier, J, Hayflick, SJ. A novel pantothenate kinase gene is defective in Hallervorden-Spatz syndrome. Nat Genet 2001;28:345–349CrossRefGoogle ScholarPubMed
Bertrand, E. Neurodegeneration with brain iron accumulation, type-I (NBIA-I) (formerly Hallervorden-Spatz disease). Part I: clinical manifestation and treatment (In Polish). Neurol Neurochir Pol 2002;36:947–958Google Scholar
Bertrand, E. Neurodegeneration with brain iron accumulation, type-I (NBIA-I) (formerly Hallervorden-Spatz disease). Part II: neuropathologic manifestation, novel genetic aspects and pathogenesis (In Polish). Neurol Neurochir Pol 2002;36:1163–1171Google Scholar
Waschke, KF, Kalenka, A, Hinkelbein, J. Degenerative ZNS-Erkrankungen. In: Wappler, F, Tonner, P, Buerkle, H. ed. Anästhesie und Begleiterkrankungen. Stuttgart, Germany: Thieme: 2005;309–332Google Scholar
Harper, PS. Naming of syndromes and unethical activities: the case of Hallervorden and Spatz. Lancet 1996;348:1224–1225CrossRefGoogle ScholarPubMed
Jacoby, R, Oppenheimer, C. Naming of syndromes. Lancet 1996;348:1662Google Scholar
Shevell, M. Racial hygiene, active euthanasia, and Julius Hallervorden. Neurology 1992;42:2214–2219CrossRefGoogle ScholarPubMed
Shevell, M. Naming of syndromes. Lancet 1996;348:1662Google Scholar
Shevell, M. Hallervorden and history. N Engl J Med 2003;384:3–4CrossRefGoogle Scholar
Sheehy, EC, Longhurst, P, Deidre, P, Dandekar, M. Self-inflicted injury in a case of Hallervorden-Spatz disease. Int J Paediatr Dent 1999;9:299–302CrossRefGoogle Scholar
Gregory, AM, Hayflick, SJ. Neurodegeneration with brain iron accumulation [WWW document]. Orphanet Encyclopedia 2004. URL http://orpha.net/data/patho/GB/uk-NBIA.pdf [accessed on 19 June 2006]Google Scholar
Cossu, G, Melis, M, Floris, G, Hayflick, S, Spissu, A. Hallervorden Spatz syndrome (pantothenate kinase associated neurodegeneration) in 2 Sardinian brothers with homozygotous mutation in the PANK 2 gene. J Neurol 2002;249:1599–1600CrossRefGoogle Scholar
Halliday, W. The nosology of Hallervorden-Spatz disease. J Neurol Sci 1995;134(Suppl):84–91CrossRefGoogle ScholarPubMed
Guillerman, GP. The eye-of-the-tiger sign. Radiology 2000;217:895–896CrossRefGoogle ScholarPubMed
Sethi, KD, Adams, RJ, Loring, DW, Elgammal, T. Hallervorden-Spatz syndrome: clinical and magnetic resonance imaging correlations. Ann Neurol 1988;24:692–694CrossRefGoogle ScholarPubMed
Sharma, MC, Aggarwal, N, Bihari, Met al. Hallervorden Spatz disease: MR and pathological findings of a rare case. Neurol India 2005;53:102–104Google ScholarPubMed
Hayflick, SJ. Pantothenate kinase-associated neurodegeneration (formerly Hallervorden-Spatz Syndrome). J Neurol Sci 2003;207:106–107CrossRefGoogle Scholar
Rock, CO, Calder, RB, Karim, MA, Jackowski, S. Pantothenate kinase regulation of intracellular concentration of coenzyme A. J Biol Chem 2000;275:1377–1383CrossRefGoogle ScholarPubMed
Taylor, TD, Litt, M, Kramer, Pet al. Homozygosity mapping of Hallervorden-Spatz syndrome to chromosome 20p12.3-p13. Nat Genet 1996;14:479–481CrossRefGoogle ScholarPubMed
Higgins, JJ, Patterson, MC, Papadopoulos, NM, Brady, RO, Pentchev, PG, Barton, NW. Hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration (HARP syndrome). Neurology 1992;42:194–198CrossRefGoogle Scholar
Keegan, MT, Flick, RP, Matsumoto, JY, Davis, DH, Lanier, WL. Anesthetic management for two-stage computer-assisted, stereotactic thalamotomy in a child with Hallervorden-Spatz disease. J Neurosurg Anesthesiol 2000;12:107–111CrossRefGoogle Scholar
Justesen, CR, Penn, RD, Kroin, JS, Egel, RT. Stereotactic pallidotomy in a child with Hallervorden-Spatz disease. J Neurosurg 1999;90:551–554CrossRefGoogle Scholar
Tsukamoto, H, Inui, K, Taniike, Met al. A case of Hallervorden-Spatz disease: progressive and intractable dystonia controlled by bilateral thalatomy. Brain Dev 1992;14:269–272CrossRefGoogle Scholar
Balas, I, Kovacs, N, Hollody, K. Staged bilateral stereotactic pallidothalamotomy for life-threatening dystonia in a child with Hallervorden-Spatz disease. Mov Disord 2006;21:82–85CrossRefGoogle Scholar
Roy, RC, McLain, S, Wise, A, Shaffner, LD. Anesthetic management of a patient with Hallervorden-Spatz disease. Anesthesiology 1983;58:382–384CrossRefGoogle ScholarPubMed
Davis, NL, Davis, R. Anesthetic management of a patient with dystonia musculorum deformans. Anesthesiology 1975;42:630–631CrossRefGoogle ScholarPubMed